Issue 7/2008
Content (28 Articles)
Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?
Jean-François Chatal, Françoise Kraeber-Bodéré, Jacques Barbet
188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases
Amal A. El-Mabhouh, John R. Mercer
Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons
M. Jules Mattes, David M. Goldenberg
Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(l-lactic acid) microspheres in healthy pigs
M. A. D. Vente, J. F. W. Nijsen, T. C. de Wit, J. H. Seppenwoolde, G. C. Krijger, P. R. Seevinck, A. Huisman, B. A. Zonnenberg, T. S. G. A. M. van den Ingh, A. D. van het Schip
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer
Michael J. Willhauck, Bibi-Rana Sharif Samani, Ingo Wolf, Reingard Senekowitsch-Schmidtke, Hans-Jürgen Stark, Geerd J. Meyer, Wolfram H. Knapp, Burkhard Göke, John C. Morris, Christine Spitzweg
Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism
P. Mahy, X. Geets, M. Lonneux, P. Levêque, N. Christian, M. De Bast, J. Gillart, D. Labar, J. Lee, V. Grégoire
Could 99mTc-glucarate be used to evaluate tumour necrosis?
Nathalie Perek, Odile Sabido, Nathalie Le Jeune, Nathalie Prevot, Jean-Michel Vergnon, Anthony Clotagatide, Francis Dubois
Staging the Axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer
R. Ruano, M. Ramos, J. R. Garcia-Talavera, E. Serrano, A. De Arriba, J. Gonzalez-Orus, M. Iglesias, M. C. Macias
18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: Is dual time point imaging worth the effort?
Ruoh-Fang Yen, Ke-Cheng Chen, Jang-Ming Lee, Yeun-Chung Chang, Jane Wang, Mei-Fang Cheng, Yen-Wen Wu, Yung-Chie Lee
Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results
Laura L. Travaini, Giuseppe Trifirò, Laura Ravasi, Lorenzo Monfardini, Paolo Della Vigna, Guido Bonomo, Antonio Chiappa, Andrew Mallia, Mahila Ferrari, Franco Orsi, Giovanni Paganelli
The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI
G. Kong, C. Jackson, D. M. Koh, V. Lewington, B. Sharma, G. Brown, D. Cunningham, G. J. R. Cook
Is absolute quantification of dopaminergic neurotransmission studies with 123I SPECT ready for clinical use?
Habib Zaidi, Georges El Fakhri
Quantification of dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation
Cristina Crespo, Judith Gallego, Albert Cot, Carles Falcón, Santiago Bullich, Deborah Pareto, Pablo Aguiar, Josep Sempau, Francisco Lomeña, Francisco Calviño, Javier Pavía, Domènec Ros
Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT
Andrea Varrone, Valeria Sansone, Maria Teresa Pellecchia, Marianna Amboni, Elena Salvatore, Giuseppe De Michele, Alessandro Filla, Paolo Barone, Sabina Pappatà, Marco Salvatore
AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures
Erik Boot, Jan Booij, Gregor Hasler, Janneke R. Zinkstok, Lieuwe de Haan, Don H. Linszen, Thérèse A. van Amelsvoort
Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG PET study
Angelo Del Sole, Francesca Clerici, Arturo Chiti, Michela Lecchi, Claudio Mariani, Laura Maggiore, Lisa Mosconi, Giovanni Lucignani
The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism
Koen Van Laere, Ludwig Everaert, Lieven Annemans, Michel Gonce, Wim Vandenberghe, Thierry Vander Borght
ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine
Ferid Haddad, Ludovic Ferrer, Arnaud Guertin, Thomas Carlier, Nathalie Michel, Jacques Barbet, Jean-François Chatal
Treatment efficacy of combined biphosphonates and 186Re-HEDP treatment in cancer patients with bone metastases
John Koutsikos, Anastasia Leondi
Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases
Marnix G. E. H. Lam, Bernard A. Zonnenberg
Spent Technetium-99m generator body adapted for sterilization of radioactive preparations
A. Mushtaq
Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective
Paolo Zanotti-Fregonara, Domenico Rubello, Elif Hindié
The specific case of radiopharmaceuticals and GMP—activities of the Radiopharmacy Committee
C. Decristoforo, P. Elsinga, A. Faivre-Chauvet, B. Farstad, G. Meyer, R. Mikolajczak, I. Penuelas, P. Unak, G. Westera
Diffuse bone marrow uptake of 99mTc (III) DMSA in Fanconi’s anemia
Sandip Basu, Ramesh Asopa, Surendra H. Moghe
18F-FDG PET/CT imaging in tendon xanthomatosis
Dae-Weung Kim, Chang-Guhn Kim, Soon-Ah Park, Young Cheon Na
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy
Michael Lassmann, Heribert Hänscheid, Carlo Chiesa, Cecilia Hindorf, Glenn Flux, Markus Luster